Standardization of in vitro testing for cardiovascular implants in the era of European Medical Device Regulation

In case of cardiovascular implants classified as class III medical products there is a specific responsibility for manufacturers as well as regulatory authorities to follow international standards to guarantee for safety and efficacy. Fast developments of science and technology as well as novel clin...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Schmidt Wolfram, Brandt-Wunderlich Christoph, Stiehm Michael, Kaule Sebastian, Siewert Stefan, Bock Andrea, Schmitz Klaus-Peter, Kurzhals Anja, Grabow Niels
Formato: article
Lenguaje:EN
Publicado: De Gruyter 2020
Materias:
R
Acceso en línea:https://doaj.org/article/d9823466539044679c00eb19724397cc
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d9823466539044679c00eb19724397cc
record_format dspace
spelling oai:doaj.org-article:d9823466539044679c00eb19724397cc2021-12-05T14:10:42ZStandardization of in vitro testing for cardiovascular implants in the era of European Medical Device Regulation2364-550410.1515/cdbme-2020-3085https://doaj.org/article/d9823466539044679c00eb19724397cc2020-09-01T00:00:00Zhttps://doi.org/10.1515/cdbme-2020-3085https://doaj.org/toc/2364-5504In case of cardiovascular implants classified as class III medical products there is a specific responsibility for manufacturers as well as regulatory authorities to follow international standards to guarantee for safety and efficacy. Fast developments of science and technology as well as novel clinical findings create permanent needs to match the standardization. Therefore, a set of international standards is analyzed with respect to their use for particular coronary drug-eluting stents and artificial heart valves. It was found that standards (ISO, ASTM) exist for general requirements on passive implants, but also specifically relate to arterial stents, stent grafts, bioresorbable and drug-eluting stents, as well as artificial heart valves. New work items address new methods for characterization of coating integrity, particulate matter and simulated use testing. European Medical Device Regulation (MDR) requires technical expertise and capacity at Notified Bodies supported by independent test laboratories. Generally, the interest in standardization from industry, test laboratories and authorities is high, but more input from medical experts would further improve the value of standardization and its relevance for safe and even more effective implants.Schmidt WolframBrandt-Wunderlich ChristophStiehm MichaelKaule SebastianSiewert StefanBock AndreaSchmitz Klaus-PeterKurzhals AnjaGrabow NielsDe Gruyterarticlevascular stentsartificial heart valvesin-vitro testingstandardizationmedical device regulationMedicineRENCurrent Directions in Biomedical Engineering, Vol 6, Iss 3, Pp 330-333 (2020)
institution DOAJ
collection DOAJ
language EN
topic vascular stents
artificial heart valves
in-vitro testing
standardization
medical device regulation
Medicine
R
spellingShingle vascular stents
artificial heart valves
in-vitro testing
standardization
medical device regulation
Medicine
R
Schmidt Wolfram
Brandt-Wunderlich Christoph
Stiehm Michael
Kaule Sebastian
Siewert Stefan
Bock Andrea
Schmitz Klaus-Peter
Kurzhals Anja
Grabow Niels
Standardization of in vitro testing for cardiovascular implants in the era of European Medical Device Regulation
description In case of cardiovascular implants classified as class III medical products there is a specific responsibility for manufacturers as well as regulatory authorities to follow international standards to guarantee for safety and efficacy. Fast developments of science and technology as well as novel clinical findings create permanent needs to match the standardization. Therefore, a set of international standards is analyzed with respect to their use for particular coronary drug-eluting stents and artificial heart valves. It was found that standards (ISO, ASTM) exist for general requirements on passive implants, but also specifically relate to arterial stents, stent grafts, bioresorbable and drug-eluting stents, as well as artificial heart valves. New work items address new methods for characterization of coating integrity, particulate matter and simulated use testing. European Medical Device Regulation (MDR) requires technical expertise and capacity at Notified Bodies supported by independent test laboratories. Generally, the interest in standardization from industry, test laboratories and authorities is high, but more input from medical experts would further improve the value of standardization and its relevance for safe and even more effective implants.
format article
author Schmidt Wolfram
Brandt-Wunderlich Christoph
Stiehm Michael
Kaule Sebastian
Siewert Stefan
Bock Andrea
Schmitz Klaus-Peter
Kurzhals Anja
Grabow Niels
author_facet Schmidt Wolfram
Brandt-Wunderlich Christoph
Stiehm Michael
Kaule Sebastian
Siewert Stefan
Bock Andrea
Schmitz Klaus-Peter
Kurzhals Anja
Grabow Niels
author_sort Schmidt Wolfram
title Standardization of in vitro testing for cardiovascular implants in the era of European Medical Device Regulation
title_short Standardization of in vitro testing for cardiovascular implants in the era of European Medical Device Regulation
title_full Standardization of in vitro testing for cardiovascular implants in the era of European Medical Device Regulation
title_fullStr Standardization of in vitro testing for cardiovascular implants in the era of European Medical Device Regulation
title_full_unstemmed Standardization of in vitro testing for cardiovascular implants in the era of European Medical Device Regulation
title_sort standardization of in vitro testing for cardiovascular implants in the era of european medical device regulation
publisher De Gruyter
publishDate 2020
url https://doaj.org/article/d9823466539044679c00eb19724397cc
work_keys_str_mv AT schmidtwolfram standardizationofinvitrotestingforcardiovascularimplantsintheeraofeuropeanmedicaldeviceregulation
AT brandtwunderlichchristoph standardizationofinvitrotestingforcardiovascularimplantsintheeraofeuropeanmedicaldeviceregulation
AT stiehmmichael standardizationofinvitrotestingforcardiovascularimplantsintheeraofeuropeanmedicaldeviceregulation
AT kaulesebastian standardizationofinvitrotestingforcardiovascularimplantsintheeraofeuropeanmedicaldeviceregulation
AT siewertstefan standardizationofinvitrotestingforcardiovascularimplantsintheeraofeuropeanmedicaldeviceregulation
AT bockandrea standardizationofinvitrotestingforcardiovascularimplantsintheeraofeuropeanmedicaldeviceregulation
AT schmitzklauspeter standardizationofinvitrotestingforcardiovascularimplantsintheeraofeuropeanmedicaldeviceregulation
AT kurzhalsanja standardizationofinvitrotestingforcardiovascularimplantsintheeraofeuropeanmedicaldeviceregulation
AT grabowniels standardizationofinvitrotestingforcardiovascularimplantsintheeraofeuropeanmedicaldeviceregulation
_version_ 1718371811662495744